Gland Pharma Q1 FY27: revenue Rs 1,800 crore, PAT Rs 317 crore. Full results breakdown and whether the stock is a buy at current levels.

Gland Pharma share price is in focus after reports that Fosun Pharma Industrial is likely to sell a 5 percent equity stake via block deal, with the offer size pegged at Rs 2,279.5 crore and a floor price of Rs 2,763.

GE Vernova T&D India Q1 FY27: revenue Rs 1,836 crore, PAT Rs 363 crore. Full results breakdown and whether the stock is a buy at current levels.

FII DII data today shows foreign institutional investors were net sellers of Rs 2,346 crore of Indian equities on September 3, while domestic institutional investors remained net buyers at Rs 4,977 crore.

Galaxy Surfactants Q1 FY27: revenue Rs 1,785 crore, PAT Rs 166 crore. Full results breakdown and whether the stock is a buy at current levels.

Emami Realty Q1 FY27: revenue Rs 9.66 crore, loss Rs 17 crore. Full results breakdown and whether the stock is a buy at current levels.

Gold price today held steady at $4,477.10 an ounce, poised for a small weekly gain, as investors await highly anticipated US payrolls data for clues on the Federal Reserve’s next interest rate decision.

Asian markets today traded broadly higher, led by a 2 percent jump in Hong Kong’s Hang Seng, as investors pared bets on a Federal Reserve interest rate hike this month, weakening the dollar.

Dollar index today held flat at 99.01 as the Japanese yen clung to its gains against the greenback, on track for its strongest week in more than a month, with traders awaiting US payrolls data.

Crude oil price today is on track for its steepest weekly gain since mid-July, with Brent crude futures up 0.2 percent to $95.67 a barrel, as intensifying US-Iran tensions raise Middle East supply risks.